GENOMIC HEALTH INC (GHDX) Stock Analyst Ratings
NASDAQ:GHDX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to GHDX. The Buy consensus is the weighted average rating of the current analysts ratings.
GHDX was analyzed by 8 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about GHDX.
In the previous month the buy percentage consensus was at a similar level.
GHDX was analyzed by 8 analysts. More opinions would make the average more meaningful.